These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2697425)

  • 1. The use of growth factors in severe aplastic anaemia (SAA).
    Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
    N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical and practical issues concerning the use of rhGM-CSF and rhIL-3: present status.
    Jones TC
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():36-7. PubMed ID: 2180518
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
    Antin JH; Smith BR; Holmes W; Rosenthal DS
    Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of myelodysplastic syndromes].
    Hotta T
    Rinsho Ketsueki; 1990 Apr; 31(4):416-30. PubMed ID: 1696325
    [No Abstract]   [Full Text] [Related]  

  • 11. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe idiopathic congenital aplastic anemia: role of hematopoietic growth factors.
    Vermylen C; Cornu G; DeWitte M; Heremans MT; Ninane J; Brichard B
    Bone Marrow Transplant; 1993 Oct; 12(4):413-5. PubMed ID: 8275043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Colony-stimulating activities of serum from patients with severe aplastic anemia].
    Zheng Y; Chu Y; Shao Z; Wang Y; Yang P; Tian Z; Tang X; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):173-6. PubMed ID: 15622760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of colony-stimulating factors in primary hematologic disorders.
    Nimer SD
    Cancer; 1992 Aug; 70(4 Suppl):921-7. PubMed ID: 1638464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.